GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q2 2022
Top Holdings55 positions
CIGNA CORP NEW | 2.1M | $547.1M | 13.7% | $202.92 | +20.01% | 15 qtrssince 2018-Q4 | Increased 77 |
TENET HEALTHCARE CORP COM NEW | 6.8M | $358.8M | 9.0% | $20.08 | +161.76% | 15 qtrssince 2018-Q4 | Increased 65 |
GLOBAL PMTS INC | 2.4M | $260.3M | 6.5% | $153.86 | -31.20% | 7 qtrssince 2020-Q4 | Decreased 0 |
DXC TECHNOLOGY CO | 7.9M | $240.2M | 6.0% | $41.92 | -27.70% | 15 qtrssince 2018-Q4 | Increased 63 |
MCKESSON CORP | 725,839 | $236.8M | 5.9% | $144.46 | +123.15% | 15 qtrssince 2018-Q4 | Decreased 0 |
FISERV INC | 2.1M | $190.6M | 4.8% | $104.94 | -13.38% | 12 qtrssince 2019-Q3 | Unchanged 0 |
COCA COLA EUROPEAN PARTNERS | 3.2M | $165.7M | 4.1% | $47.02 | +0.43% | 6 qtrssince 2021-Q1 | Increased 63 |
US Foods Holding Corp | 4.6M | $141.9M | 3.5% | $36.34 | -15.58% | 3 qtrssince 2021-Q4 | Increased 58 |
BAXTER INTL INC | 2.2M | $139.6M | 3.5% | $74.57 | -19.00% | 10 qtrssince 2020-Q1 | Decreased 0 |
APTIV PLC | 1.5M | $132.7M | 3.3% | $124.25 | -25.34% | 7 qtrssince 2020-Q4 | Increased 72 |
CHANGE HEALTHCARE INC | 4.3M | $99.8M | 2.5% | — | — | 5 qtrssince 2021-Q2 | Increased 76 |
CENTENE CORP DEL | 1.1M | $90.8M | 2.3% | $72.42 | +16.83% | 5 qtrssince 2021-Q2 | Decreased 0 |
Uber Technologies Inc | 4.3M | $87.8M | 2.2% | $40.30 | -46.72% | 5 qtrssince 2021-Q2 | Increased 57 |
CORTEVA INC | 1.6M | $84.5M | 2.1% | $33.53 | +56.52% | 11 qtrssince 2019-Q4 | Increased 52 |
DUPONT DE NEMOURS INC | 1.5M | $83.6M | 2.1% | $84.91 | -24.07% | 7 qtrssince 2020-Q4 | Decreased 0 |
F M C CORP | 758,499 | $81.2M | 2.0% | $79.25 | +20.03% | 15 qtrssince 2018-Q4 | Increased 82 |
Encompass Health Corporation | 1.4M | $77M | 1.9% | $53.79 | -18.59% | 4 qtrssince 2021-Q3 | Increased 50 |
Amazon.com, Inc. | 715,164 | $76M | 1.9% | $164.76 | -35.54% | 3 qtrssince 2021-Q4 | Increased 75 |
ELEMENT SOLUTIONS INC COM | 4.2M | $74.2M | 1.9% | $14.72 | +14.32% | 14 qtrssince 2019-Q1 | Increased 61 |
VALVOLINE INC | 2M | $57.6M | 1.4% | $31.12 | -7.33% | 2 qtrssince 2022-Q1 | Increased 53 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $4B across 55 positions as of Q2 2022. Top holdings: CI (13.7%), THC (9.0%), GPN (6.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 6 new positions, 11 exits, 24 increased. Top move: FMC (INCREASED, conviction 82). Portfolio: $4.0B across 55 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR